EyePoint

EYPTNasdaq United States Industrials Biotechnology: Laboratory Analytical Instruments

Market cap

$31.123 M

$0.36 -8.61%

Close of 6 Nov 2026

As of 6 Nov 2026, EyePoint (EYPT) has a market capitalization of $31.1M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$31.4M

#2854 by revenue

Earnings

-$232.0M

Loss-making

Shares outstanding

86,212,138

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Laboratory Analytical Instruments, ranked by market cap

All 22 →

#17PrecipioPRPO$34.0M
#18Rapid Micro BiosystemsRPID$31.2M
#19EyePointEYPT$31.1M
#20Circle8 GroupCIRC$23.8M
#21Bionano GenomicsBNGO$15.5M

Insiders buying

All insider buying →

One open-market purchase by officers and directors of EyePoint, worth $52.3K. Grants and option exercises are excluded.

Karen L. Zaderej$52.3K
10,600 shares at $4.93 on 18 Aug 2026 · filed 18 Aug 2026

What if EyePoint were worth as much as…

Open the what-if tool →

Gold $28.2T

$327,527.82

Per share 907,279× higher

Bitcoin $1.53T

$17,721.96

Per share 49,091× higher

Apple $5.02T

$58,179.54

Per share 161,162× higher

Or at a round number

$50.0M $100.0M $200.0M $500.0M

Where these numbers come from

Share counts and financials for EyePoint are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.